| abstract |
the present invention relates to pharmaceutical compositions, such as tablets that exhibit delayed release properties when administered either as whole tablets or compressed media. the invention is also directed to delayed-release tablets that comprise oral deferiprone, for which twice-daily administration is bioequivalent to the same daily dose as an immediate-release tablet administered three times a day. the invention is also directed to methods for producing and using them. |